Literature DB >> 21134636

The third conformation of p38α MAP kinase observed in phosphorylated p38α and in solution.

Radha Akella1, Xiaoshan Min, Qiong Wu, Kevin H Gardner, Elizabeth J Goldsmith.   

Abstract

MAPKs engage substrates, MAP2Ks, and phosphatases via a docking groove in the C-terminal domain of the kinase. Prior crystallographic studies on the unphosphorylated MAPKs p38α and ERK2 defined the docking groove and revealed long-range conformational changes affecting the activation loop and active site of the kinase induced by peptide. Solution NMR data presented here for unphosphorylated p38α with a MEK3b-derived peptide (p38α/pepMEK3b) validate these findings. Crystallograhic data from doubly phosphorylated active p38α (p38α/T∗GY∗/pepMEK3b) reveal a structure similar to unphosphorylated p38α/MEK3b, and distinct from phosphorylated p38γ (p38γ/T∗GY∗) and ERK2 (ERK2/T∗EY∗). The structure supports the idea that MAP kinases adopt three distinct conformations: unphosphorylated, phosphorylated, and a docking peptide-induced form.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21134636     DOI: 10.1016/j.str.2010.09.015

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  17 in total

1.  Structural basis for the regulation of the mitogen-activated protein (MAP) kinase p38α by the dual specificity phosphatase 16 MAP kinase binding domain in solution.

Authors:  Ganesan Senthil Kumar; Heiko Zettl; Rebecca Page; Wolfgang Peti
Journal:  J Biol Chem       Date:  2013-08-07       Impact factor: 5.157

Review 2.  Molecular basis of MAP kinase regulation.

Authors:  Wolfgang Peti; Rebecca Page
Journal:  Protein Sci       Date:  2013-10-19       Impact factor: 6.725

Review 3.  MAP kinase modules: the excursion model and the steps that count.

Authors:  Alexander T Piala; John M Humphreys; Elizabeth J Goldsmith
Journal:  Biophys J       Date:  2014-11-04       Impact factor: 4.033

4.  Allosteric enhancement of MAP kinase p38α's activity and substrate selectivity by docking interactions.

Authors:  Yuji Tokunaga; Koh Takeuchi; Hideo Takahashi; Ichio Shimada
Journal:  Nat Struct Mol Biol       Date:  2014-07-20       Impact factor: 15.369

5.  Functional divergence caused by mutations in an energetic hotspot in ERK2.

Authors:  Clinton A Taylor; Kevin W Cormier; Shannon E Keenan; Svetlana Earnest; Steve Stippec; Chonlarat Wichaidit; Yu-Chi Juang; Junmei Wang; Stanislav Y Shvartsman; Elizabeth J Goldsmith; Melanie H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-11       Impact factor: 11.205

6.  Solution NMR insights into docking interactions involving inactive ERK2.

Authors:  Andrea Piserchio; Mangalika Warthaka; Ashwini K Devkota; Tamer S Kaoud; Sunbae Lee; Olga Abramczyk; Pengyu Ren; Kevin N Dalby; Ranajeet Ghose
Journal:  Biochemistry       Date:  2011-04-19       Impact factor: 3.162

7.  Structural basis of p38α regulation by hematopoietic tyrosine phosphatase.

Authors:  Dana M Francis; Bartosz Różycki; Dorothy Koveal; Gerhard Hummer; Rebecca Page; Wolfgang Peti
Journal:  Nat Chem Biol       Date:  2011-11-06       Impact factor: 15.040

8.  Membrane skeletal association and post-translational allosteric regulation of Toxoplasma gondii GAPDH1.

Authors:  Rashmi Dubey; Bart L Staker; Ian T Foe; Matthew Bogyo; Peter J Myler; Huân M Ngô; Marc-Jan Gubbels
Journal:  Mol Microbiol       Date:  2016-12-23       Impact factor: 3.501

9.  Dynamic activation and regulation of the mitogen-activated protein kinase p38.

Authors:  Ganesan Senthil Kumar; Michael W Clarkson; Micha B A Kunze; Daniele Granata; A Joshua Wand; Kresten Lindorff-Larsen; Rebecca Page; Wolfgang Peti
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-16       Impact factor: 11.205

10.  Docking interactions of hematopoietic tyrosine phosphatase with MAP kinases ERK2 and p38α.

Authors:  Andrea Piserchio; Dana M Francis; Dorothy Koveal; Kevin N Dalby; Rebecca Page; Wolfgang Peti; Ranajeet Ghose
Journal:  Biochemistry       Date:  2012-10-05       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.